{"transactions":[{"id":929093,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-28T16:30:13.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":1230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest in full on the earlier of (i) January 27, 2027, or (ii) the day of the Issuer's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":1230,"derivative":{"exercise_price":2.94,"expiration_date":"2036-01-26","underlying":"Common Stock","underlying_shares":1230},"source":{"system":"sec-edgar","filing":"0001871563-26-000002","document":"form4-01282026_040107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000187156326000002/form4-01282026_040107.xml","form_type":"4"}},{"id":1479344,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T18:05:07.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest in full on the earlier of (i) June 13, 2025, or (ii) the day of the Issuer's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":16000,"derivative":{"exercise_price":3.03,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001415889-24-017010","document":"form4-06142024_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000141588924017010/form4-06142024_060603.xml","form_type":"4"}},{"id":1662119,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-02-02T16:40:35.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":480319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, and shall vest with respect to 33% of the RSUs, on each of  July 31, 2024 and July 31, 2025, respectively, and with respect to 34% of the RSUs, on July 31, 2026. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":655896,"source":{"system":"sec-edgar","filing":"0001415889-24-002321","document":"form4-02022024_090226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000141588924002321/form4-02022024_090226.xml","form_type":"4"}},{"id":1849930,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T16:46:11.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest in full on the earlier of (i) June 15, 2024, or (ii) the day of the Issuer's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":8200,"derivative":{"exercise_price":1.42,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0001209191-23-038440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000120919123038440/doc4.xml","form_type":"4"}},{"id":2022955,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & Chief Scientific Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-02-10T19:59:25.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":116340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33% of the shares subject to the option award shall vest on each of August 8, 2023 and August 8, 2024, respectively, and 34% of the shares subject to the option award shall vest on August 8, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":116340,"derivative":{"exercise_price":1.59,"expiration_date":"2033-02-07","underlying":"Ordinary Shares","underlying_shares":116340},"source":{"system":"sec-edgar","filing":"0001209191-23-008566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000120919123008566/doc4.xml","form_type":"4"}},{"id":2022954,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO & Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2023-02-10T19:59:25.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":58100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, and shall vest with respect to 33% of the RSUs, on each of August 8, 2023 and August 8, 2024, respectively, and with respect to 34% of the RSUs, on August 8, 2025. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":175577,"source":{"system":"sec-edgar","filing":"0001209191-23-008566","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000120919123008566/doc4.xml","form_type":"4"}},{"id":2224341,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T16:11:02.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over one (1) year, with one hundred per cent (100%) of the award vesting on the first anniversary of the date of grant subject to the reporting person's continuous service through the vesting date."}],"balance_after":3500,"derivative":{"exercise_price":2.08,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-22-003377","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000117911022003377/edgar.xml","form_type":"4"}},{"id":2608722,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-10T19:05:24.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":6635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over three  (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date."}],"balance_after":6635,"derivative":{"exercise_price":13.6,"expiration_date":"2031-08-05","underlying":"Common Stock","underlying_shares":6635},"source":{"system":"sec-edgar","filing":"0001179110-21-008097","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000117911021008097/edgar.xml","form_type":"4"}},{"id":2635035,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":68605,"kind":"person","name":"Simantov Ronit","position":1,"cik":"0001871563","reported_name":"Simantov Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-13T16:25:24.000Z","date":"2021-07-12","kind":"grant","acquired":true,"shares":83212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares subject to the option shall vest on each of the first three (3) annual anniversaries of the date of grant."}],"balance_after":83212,"derivative":{"exercise_price":5.3,"expiration_date":"2031-07-12","underlying":"Common Stock","underlying_shares":83212},"source":{"system":"sec-edgar","filing":"0000899243-21-028209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871563/000089924321028209/doc4.xml","form_type":"4"}}]}